Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review
Open accessAbstract
Aims/hypothesis Insulin resistance, which manifests itself as endogenous glucose overproduction and reduced insulin-mediated glucose uptake, is a core defect in type 2 diabetes. Metformin and the peroxisome proliferator-activated receptor-gamma agonists, the thiazolidinediones (TZDs), both lower glucose, although their mechanism of action is still subject to debate. This review analyses the evidence relevant to these mechanisms in vivo.Materials and methods A systematic search of MEDLINE identified a total of 42 clinical studies that investigated the effects of TZDs (n=23) and/or metformin (n=19) on endogenous glucose production (using tracer glucose techniques) and peripheral glucose disposal (using the euglycaemic-hyperinsulinaemic clamp) in patients with type 2 diabetes (n=549). The original variables assessed were converted into standardised units and their mean group values were listed separately for open and placebo-controlled studies. Statistical analysis was scarried out, treating mean group values as individual values and comparing results (both as absolute values and percentage changes from baseline) across study categories (open vs placebo-controlled, TZDs vs metformin).Results Both TZDs and metformin enhance insulin suppression of endogenous glucose production and fasting plasma glucose clearance. TZDs, but not metformin, also improve insulin-mediated glucose uptake at all insulin levels.Conclusions/interpretation In patients with type 2 diabetes, metformin improves fasting hepatic insulin sensitivity and glucose clearance; TZDs improve fasting hepatic insulin sensitivity and glucose clearance, and potentiate glucose disposal under insulinised conditions.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Metformin increases insulin suppression of endogenous glucose production by the liver.
“an increased insulin suppression of endogenous glucose production by the liver(44, 45)”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [44]
Metformin reduces glucose absorption by the gastro-intestinal tract.
“reduction of glucose absorbtion by the gastro-intestinal tract(44, 45)”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [44]
Metformin decreases hepatic glucose production by suppression of gluconeogenesis.
“a decreased in hepatic glucose production by suppression of gluconeogenesis(44, 45)”
From Metformin, the Aspirin of the 21st Century: Its Role in Gestational Diabetes Mellitus, Prevention of Preeclampsia and Cancer, and the Promotion of Longevity (2017) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with Troglitazone
Nolan, J. J., Ludvik, B. H., Beerdsen, P., Joyce, M., & Olefsky, J. M. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411033311803 · Cited by 925 · see citing works
Ferrannini, E., Natali, A., Bell, P., Cavallo-Perin, P., Lalic, N., & Mingrone, G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119628 · Cited by 898 · see citing works
Self-citationEfficacy and Metabolic Effects of Metformin and Troglitazone in Type II Diabetes Mellitus
Inzucchi, S. E., Maggs, D. G., Spollett, G. R., Page, S. L., Rife, F. S., Walton, V., & Shulman, G. I. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381303 · Cited by 794 · see citing works
International Textbook of Diabetes Mellitus
(2003) · Wiley eBooks · doi:10.1002/0470862092 · Cited by 743 · see citing works
Treatment of insulin resistance with peroxisome proliferator–activated receptor γ agonists
Olefsky, J. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10843 · Cited by 536 · see citing works
The Effect of Insulin Treatment on Insulin Secretion and Insulin Action in Type II Diabetes Mellitus
Garvey, W. T., Olefsky, J. M., Griffin, J., Hamman, R. F., & Kolterman, O. G. (1985) · Diabetes · doi:10.2337/diab.34.3.222 · Cited by 488 · see citing works
Hundal, R. S., & Inzucchi, S. E. (2003) · Drugs · doi:10.2165/00003495-200363180-00001 · Cited by 312 · see citing works
Schernthaner, G., Matthews, D. R., Charbonnel, B. H., Markolf Hanefeld, E., & Brunetti, P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030861 · Cited by 268 · see citing works
Mechanisms of Early Insulin-Sensitizing Effects of Thiazolidinediones in Type 2 Diabetes
Tonelli, J., Li, W., Kishore, P., Pajvani, U. B., Kwon, E., Weaver, C. L., Scherer, P. E., & Hawkins, M. A. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1621 · Cited by 249 · see citing works
Hundal, H. S., Ramlal, T., Reyes, R., Leiter, L. A., & Klip, A. (1992) · Endocrinology · doi:10.1210/endo.131.3.1505458 · Cited by 243 · see citing works
Robertson, R. P., Zhang, H. J., Pyzdrowski, K. L., & Walseth, T. F. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115865 · Cited by 232 · see citing works
Perriello, G., Misericordia, P., Volpi, E., Santucci, A., Santucci, C., Ferrannini, E., Ventura, M. M., Santeusanio, F., Brunetti, P., & Bolli, G. B. (1994) · Diabetes · doi:10.2337/diab.43.7.920 · Cited by 227 · see citing works
Self-citationRosiglitazone Improves Insulin Sensitivity and Lowers Blood Pressure in Hypertensive Patients
Raji, A., Seely, E. W., Bekins, S. A., Williams, G. H., & Simonson, D. C. (2003) · Diabetes Care · doi:10.2337/diacare.26.1.172 · Cited by 215 · see citing works
Andrews, W. J., Vasquez, B., NAGULESPARAN, M., Klimeś, I., Foley, J. E., Unger, R. H., & Reaven, G. M. (1984) · Diabetes · doi:10.2337/diab.33.7.634 · Cited by 194 · see citing works
Kruszynska, Y. T., Yu, J., Olefsky, J. M., & Sobel, B. E. (2000) · Diabetes · doi:10.2337/diabetes.49.4.633 · Cited by 184 · see citing works
Vascular Effects of Improving Metabolic Control With Metformin or Rosiglitazone in Type 2 Diabetes
Natali, A., Baldeweg, S. E., Toschi, E., Capaldo, B., Barbaro, D., Gastaldelli, A., Yudkin, J. S., & Ferrannini, E. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1349 · Cited by 180 · see citing works
Self-citationRe-evaluation of a biguanide, metformin: mechanism of action and tolerability
Sirtori, C. R. (1994) · Pharmacological Research · doi:10.1016/1043-6618(94)80104-5 · Cited by 175 · see citing works
Hällsten, K., Virtanen, K. A., Lönnqvist, F., Sipilä, H. T., Oksanen, A., Viljanen, T., Rönnemaa, T., Viikari, J. S. A., Knuuti, J. M., & Nuutila, P. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3479 · Cited by 165 · see citing works
Pavo, I. J., Jermendy, G., Várkonyi, T. T., Kerényi, Z., Gyimesi, A., Shoustov, S., Shestakova, M. V., Herz, M., Johns, D., Schluchter, B. J., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021786 · Cited by 163 · see citing works
Johnson, A. B., Webster, J. M., Sum, C. F., Heseltine, L., Argyraki, M., Cooper, B. G., & Taylor, R. (1993) · Metabolism · doi:10.1016/0026-0495(93)90284-u · Cited by 150 · see citing works
Groop, L., Wid�n, E., & Ferrannini, E. (1993) · Diabetologia · doi:10.1007/bf00400814 · Cited by 136 · see citing works
Self-citationMetformin improves peripheral but not hepatic insulin action in obese patients with type II diabetes
Nielsen, O. H., Schmitz, O., Andersen, P. H., Beck‐Nielsen, H., & Pedersen, O. B. (1989) · European Journal of Endocrinology · doi:10.1530/acta.0.1200257 · Cited by 118 · see citing works
Yu, J., Kruszynska, Y. T., Mulford, M. I., & Olefsky, J. M. (1999) · Diabetes · doi:10.2337/diabetes.48.12.2414 · Cited by 110 · see citing works
McIntyre, D. H., Paterson, C. A., Ma, A., Ravenscroft, P. J., Bird, D., & Cameron, D. P. (1991) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1991.tb01375.x · Cited by 98 · see citing works
Inhibitory effect of metformin on intestinal glucose absorption in the perfused rat intestine
Ikeda, T., Iwata, K., & Murakami, H. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00396-2 · Cited by 94 · see citing works
Karlsson, H., Hällsten, K., Björnholm, M., Tsuchida, H., Chibalin, A., Virtanen, K. A., Heinonen, O. J., Lönnqvist, F., Nuutila, P., & Zierath, J. R. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1459 · Cited by 92 · see citing works
Effects of prolonged glucose infusion on insulin secretion, clearance, and action in normal subjects
Boden, G., Ruiz, J. P. G., Kim, C. J., & Chen, X. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.270.2.e251 · Cited by 76 · see citing works
Insulin resistance: From predisposing factor to therapeutic target in type 2 diabetes
Henry, R. R. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80242-4 · Cited by 55 · see citing works
Meyer, M. M., Levin, K., Grimmsmann, T., Perwitz, N., Eirich, A., Beck‐Nielsen, H., & Klein, H. H. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2691 · Cited by 30 · see citing works
Effects of Troglitazone in Young First-Degree Relatives of Patients With Type 2 Diabetes
Levin, K., Nielsen, O. H., Henriksen, J. E., & Beck‐Nielsen, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.148 · Cited by 18 · see citing works
Insulin ActionsIn Vivo: Glucose Metabolism
Ferrannini, E., & DeFronzo, R. A. (2004) · Wiley eBooks · doi:10.1002/0470862092.d0305 · Cited by 16 · see citing works
Self-citationCuber, J.-C., Bosshard, A., Vidal, H., Vega, F., Wiernsperger, N. F., & Rapin, J. R. (1994) · PubMed · Cited by 14 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
DeFronzo, R. A. (2009) · Diabetes · doi:10.2337/db09-9028 · Cited by 3,016 · see citing works
The mechanisms of action of metformin
Rena, G., Hardie, D. G., & Pearson, E. R. (2017) · Diabetologia · doi:10.1007/s00125-017-4342-z · Cited by 2,287 · see citing works
Cellular and molecular mechanisms of metformin: an overview
Viollet, B., Guigas, B., Garcia, N. S., Leclerc, J., Foretz, M., & Andreelli, F. (2012) · Clinical Science · doi:10.1042/cs20110386 · Cited by 1,720 · see citing works
Metformin: from mechanisms of action to therapies
Foretz, M., Guigas, B., Bertrand, L., Pollak, M., & Viollet, B. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.09.018 · Cited by 1,501 · see citing works
Thomas, N., Senthil, K., & Kapoor, N. (2016) · Jaypee Brothers Medical Publishers (P) Ltd. eBooks · doi:10.5005/jp/books/12651_7 · Cited by 943 · see citing works
Type 2 diabetes across generations: from pathophysiology to prevention and management
Nolan, C. J., Damm, P., & Prentki, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60614-4 · Cited by 923 · see citing works
Fullerton, M. D., Galic, S., Marcinko, K., Sikkema, S., Pulinilkunnil, T., Chen, Z.-P., O'Neill, H. M., Ford, R. J., Palanivel, R., O'Brien, M., et al. (2013) · Nature Medicine · doi:10.1038/nm.3372 · Cited by 893 · see citing works
Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus
Foretz, M., Guigas, B., & Viollet, B. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0242-2 · Cited by 686 · see citing works
AMPK as a Therapeutic Target for Treating Metabolic Diseases
Day, E. A., Ford, R. J., & Steinberg, G. R. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.05.004 · Cited by 620 · see citing works
Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents
Di Pino, A., & DeFronzo, R. A. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00141 · Cited by 535 · see citing works
Thiazolidinediones and the promise of insulin sensitization in type 2 diabetes
Soccio, R. E., Chen, E. R., & Lazar, M. A. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.08.005 · Cited by 518 · see citing works
Metformin pathways: pharmacokinetics and pharmacodynamics
Gong, L., Goswami, S., Giacomini, K. M., Altman, R. B., & Klein, T. E. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283559b22 · Cited by 495 · see citing works
From pre-diabetes to diabetes: diagnosis, treatments and translational research
Khan, R., Chua, Z., Tan, J., Yang, Y., Liao, Z., & Zhao, Y. (2019) · Medicina · doi:10.3390/medicina55090546 · Cited by 484 · see citing works
Kooy, A., de Jager, J., Lehert, P., Bets, D., Wulffelé, M. G., Donker, A. J. M., & Stehouwer, C. D. A. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.20 · Cited by 440 · see citing works
Hawley, S. A., Ford, R. J., Smith, B. K., Gowans, G. J., Mancini, S. J., Pitt, R. D., Day, E. A., Salt, I. P., Steinberg, G. R., & Hardie, D. G. (2016) · Diabetes · doi:10.2337/db16-0058 · Cited by 398 · see citing works
Dunning, B. E., & Gerich, J. E. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0026 · Cited by 369 · see citing works
Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial
Haukeland, J. W., Konopski, Z., Eggesbø, H. B., von Volkmann, H. L., Raschpichler, G., Bjøro, K., Haaland, T., Løberg, E. M., & Birkeland, K. (2009) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520902845268 · Cited by 323 · see citing works
DeFronzo, R. A., & Abdul‐Ghani, M. A. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.03.013 · Cited by 318 · see citing works
Pathophysiologic Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes
DeFronzo, R. A., Eldor, R., & Abdul‐Ghani, M. A. (2013) · Diabetes Care · doi:10.2337/dcs13-2011 · Cited by 316 · see citing works
Hypothalamic AMPK: a canonical regulator of whole-body energy balance
López, M., Nogueiras, R., Tena‐Sempere, M., & Diéguez, C. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.67 · Cited by 312 · see citing works
Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier
Divakaruni, A. S., Wiley, S. E., Rogers, G. W., Andreyev, A. Y., Petrosyan, S., Loviscach, M., Wall, E. A., Yadava, N., Heuck, A. P., Ferrick, D. A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303360110 · Cited by 308 · see citing works
Stephenne, X., Foretz, M., Taleux, N., van der Zon, G. C., Sokal, E., Hue, L., Viollet, B., & Guigas, B. (2011) · Diabetologia · doi:10.1007/s00125-011-2311-5 · Cited by 287 · see citing works
Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention
Gottwald‐Hostalek, U., Gwilt, M., & Hildemann, S. K. (2015) · Drugs · doi:10.1007/s40265-015-0416-8 · Cited by 278 · see citing works
Januś, A., Szahidewicz-Krupska, E., Mazur, G. J., & Doroszko, A. (2016) · Mediators of Inflammation · doi:10.1155/2016/3634948 · Cited by 271 · see citing works
Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes
Ferrannini, E., & DeFronzo, R. A. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv239 · Cited by 256 · see citing works
Self-citationInsulin resistance and insulin sensitizing agents
Mastrototaro, L., & Roden, M. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154892 · Cited by 259 · see citing works
The metabolism of proline, a stress substrate, modulates carcinogenic pathways
Phang, J. M., Donald, S. P., Pandhare, J., & Liu, Y. (2008) · Amino Acids · doi:10.1007/s00726-008-0063-4 · Cited by 252 · see citing works
Romero, R., Erez, O., Hüttemann, M., Maymon, E., Panaitescu, B., Conde-Agudelo, A., Pacora, P., Yoon, B. H., & Grossman, L. I. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.06.003 · Cited by 253 · see citing works
Diamanti‐Kandarakis, E., Christakou, C. D., Kandaraki, E., & Economou, F. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0733 · Cited by 246 · see citing works
Renal glucose reabsorption inhibitors to treat diabetes
Bailey, C. J. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.11.011 · Cited by 217 · see citing works
Kusuhara, H., Ito, S., Kumagai, Y., Jiang, M., Shiroshita, T., Moriyama, Y., Inoue, K., Yuasa, H., & Sugiyama, Y. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.36 · Cited by 216 · see citing works
Cariou, B., Hanf, R., Lambert-Porcheron, S., Zaïr, Y., Sauvinet, V., Noël, B., Flet, L., Vidal, H., Staels, B., & Laville, M. (2013) · Diabetes Care · doi:10.2337/dc12-2012 · Cited by 216 · see citing works
Nesti, L., & Natali, A. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.04.009 · Cited by 211 · see citing works
Self-citationZhang, H., Zhai, Z., Wang, Y., Zhang, J., Wu, H., Wang, Y., Li, C., Li, D., Lu, L., Wang, X., et al. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.10.530 · Cited by 207 · see citing works
Zhou, K., Donnelly, L. A., Kimber, C. H., Donnan, P. T., Doney, A. S. F., Leese, G., Hattersley, A. T., McCarthy, M. I., Morris, A. D., Palmer, C. N. A., et al. (2009) · Diabetes · doi:10.2337/db08-0896 · Cited by 187 · see citing works
The effects of metformin on autophagy
Lu, G., Wu, Z., Shang, J., Xie, Z., Chen, C., & zhang, C. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111286 · Cited by 179 · see citing works
The Metabolism of Proline as Microenvironmental Stress Substrate
Phang, J. M., Pandhare, J., & Liu, Y. (2008) · Journal of Nutrition · doi:10.1093/jn/138.10.2008s · Cited by 175 · see citing works
The Metformin Mechanism on Gluconeogenesis and AMPK Activation: The Metabolite Perspective
Agius, L., Ford, B. E., & Chachra, S. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093240 · Cited by 178 · see citing works
Geerling, J. J., Boon, M. R., van der Zon, G. C., van den Berg, S. A. A., van den Hoek, A. M., Lombès, M., Princen, H. M. G., Havekes, L. M., Rensen, P. C. N., & Guigas, B. (2013) · Diabetes · doi:10.2337/db13-0194 · Cited by 166 · see citing works
Turner, N. A., Hariharan, K., Tid-Ang, J. D., Frangioudakis, G., Beale, S. M., Wright, L. E., Zeng, X., Leslie, S. J., Li, J.-Y., Kraegen, E. W., et al. (2009) · Diabetes · doi:10.2337/db09-0784 · Cited by 162 · see citing works
Ford, R. J., Fullerton, M. D., Pinkosky, S. L., Day, E. A., Scott, J. W., Oakhill, J. S., Bujak, A. L., Smith, B. K., Crane, J. D., Blümer, R. M. E., et al. (2015) · Biochemical Journal · doi:10.1042/bj20150125 · Cited by 160 · see citing works
The Current and Potential Therapeutic Use of Metformin—The Good Old Drug
Drzewoski, J., & Hanefeld, M. (2021) · Pharmaceuticals · doi:10.3390/ph14020122 · Cited by 165 · see citing works
Lee, C. B., Chae, S. U., Jo, S. J., Jerng, U. M., & Bae, S. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073566 · Cited by 149 · see citing works
Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes
Ahren, B. (2013) · Vascular Health and Risk Management · doi:10.2147/vhrm.s33934 · Cited by 148 · see citing works
Metformin and other antidiabetic agents in renal failure patients
Lalau, J., Arnouts, P., Sharif, A., & Broe, M. E. D. (2014) · Kidney International · doi:10.1038/ki.2014.19 · Cited by 144 · see citing works
Metformin, cancer and glucose metabolism
Salani, B., Río, A. D., Marini, C., Sambuceti, G., Cordera, R., & Maggi, D. C. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0284 · Cited by 126 · see citing works
Kaisar, M. A., Villalba, H., Prasad, S., Liles, T., Sifat, A. E., Sajja, R. K., Abbruscato, T. J., & Cucullo, L. (2017) · Redox Biology · doi:10.1016/j.redox.2017.06.006 · Cited by 128 · see citing works
In Vivo Actions of Peroxisome Proliferator–Activated Receptors
Eldor, R., DeFronzo, R. A., & Abdul‐Ghani, M. A. (2013) · Diabetes Care · doi:10.2337/dcs13-2003 · Cited by 127 · see citing works
Metformin ameliorates ionizing irradiation-induced long-term hematopoietic stem cell injury in mice
Xu, G., Wu, H., Zhang, J., Li, D., Wang, Y., Wang, Y., Zhang, H., Lu, L., Li, C., Huang, S. M., et al. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.045 · Cited by 127 · see citing works
New Drugs for Type 2 Diabetes Mellitus
Krentz, A. J., Patel, M., & Bailey, C. J. (2008) · Drugs · doi:10.2165/00003495-200868150-00005 · Cited by 121 · see citing works
Hasan, A. A., Madkor, H., & Wageh, S. (2013) · Drug Delivery · doi:10.3109/10717544.2013.779332 · Cited by 122 · see citing works
Azuma, K., Rádiková, Ž., Mancino, J., Toledo, F. G. S., Thomas, E., Kangani, C. O., Man, C. D., Cobelli, C., Holst, J. J., Deacon, C. F., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1369 · Cited by 121 · see citing works
Ligands for the Nuclear Peroxisome Proliferator-Activated Receptor Gamma
Sauer, S. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.06.010 · Cited by 118 · see citing works
Prattichizzo, F., Giuliani, A., Mensa’, E., Sabbatinelli, J., Nigris, V. D., Rippo, M. R., Sala, L. L., Procopio, A. D., Olivieri, F., & Ceriello, A. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.10.003 · Cited by 111 · see citing works
HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options
Mallewa, J. E., Wilkins, E., Vilar, J., Mallewa, M., Doran, D. A., Back, D. J., & Pirmohamed, M. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn251 · Cited by 109 · see citing works
Clinical utility of metabolic syndrome severity scores: considerations for practitioners
DeBoer, M. D., & Gurka, M. J. (2017) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s101624 · Cited by 108 · see citing works
Therapeutic Manipulation of Myocardial Metabolism
Honka, H., Solis‐Herrera, C., Triplitt, C. L., Norton, L., Butler, J., & DeFronzo, R. A. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.02.057 · Cited by 98 · see citing works
Metformin Improves Peripheral Insulin Sensitivity in Youth With Type 1 Diabetes
Cree-Green, M., Bergman, B. C., Cengiz, E., Fox, L. A., Hannon, T. S., Miller, K., Nathan, B., Pyle, L., Kahn, D., Tansey, M., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00129 · Cited by 101 · see citing works
Do We Still Need Pioglitazone for the Treatment of Type 2 Diabetes? A risk-benefit critique in 2013
Schernthaner, G., Currie, C. J., & Schernthaner, G.-H. (2013) · Diabetes Care · doi:10.2337/dcs13-2031 · Cited by 100 · see citing works
Dang, Q., Kasibhatla, S. R., Reddy, K. R., Jiang, T., Reddy, M. R., Potter, S. C., Fujitaki, J. M., van Poelje, P. D., Huang, J., Lipscomb, W. N., et al. (2007) · Journal of the American Chemical Society · doi:10.1021/ja074871l · Cited by 100 · see citing works
Metformin in Reproductive Biology
Faure, M., Bertoldo, M. J., Khoueiry, R., Bongrani, A., Brion, F., Giulivi, C., Dupont, J., & Froment, P. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00675 · Cited by 100 · see citing works
Medical Antihyperglycaemic Treatment of Type 2 Diabetes Mellitus
Matthaei, S., Bierwirth, R., Fritsche, A., Gallwitz, B., Häring, H., Joost, H., Kellerer, M., Kloos, C., Kunt, T., Nauck, M. A., et al. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1239559 · Cited by 91 · see citing works
Esther Phielix, E., Szendroedi, J., & Roden, M. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.06.006 · Cited by 91 · see citing works
Polycystic ovary syndrome in adolescents
Rothenberg, S. S., Beverley, R. M., Barnard, E., Baradaran-Shoraka, M., & Sanfilippo, J. S. (2017) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2017.08.008 · Cited by 88 · see citing works
Mechanisms of action of metformin with special reference to cardiovascular protection
Zilov, A. V., Abdelaziz, S. I., Alshammary, A., Zahrani, A. A., Amir, A., Khalil, S. H. A., Brand, K. M. G., Elkafrawy, N., Hassoun, A. A. K., Jahed, S. A., et al. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3173 · Cited by 86 · see citing works
Pioglitazone for type 2 diabetes mellitus
Richter, B., Bandeira-Echtler, E., Bergerhoff, K., Clar, C., & Ebrahim, S. H. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006060.pub2 · Cited by 87 · see citing works
Alshawi, A., & Agius, L. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006670 · Cited by 85 · see citing works
Bone health in diabetes and prediabetes
Costantini, S., & Conte, C. (2019) · World Journal of Diabetes · doi:10.4239/wjd.v10.i8.421 · Cited by 84 · see citing works
General aspects of muscle glucose uptake
Alvim, R. D. O., CHEUHEN, M. R., MACHADO, S. R., de Sousa, A. G. P., & SANTOS, P. C. J. L. (2015) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201520140225 · Cited by 80 · see citing works
Immunometabolism of T cells and NK cells: metabolic control of effector and regulatory function
Poznanski, S. M., Barra, N. G., Ashkar, A. A., & Schertzer, J. D. (2018) · Inflammation Research · doi:10.1007/s00011-018-1174-3 · Cited by 76 · see citing works
The Importance of Mitochondrial Pyruvate Carrier in Cancer Cell Metabolism and Tumorigenesis
Ruiz-Iglesias, A., & Mañes, S. (2021) · Cancers · doi:10.3390/cancers13071488 · Cited by 76 · see citing works
Xie, J., Ye, J., Cai, Z., Luo, Y., Zhu, X., Deng, Y., Feng, Y., Liang, Y., Liu, R., Han, Z., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2852 · Cited by 74 · see citing works
Differential Effects of Krill Oil and Fish Oil on the Hepatic Transcriptome in Mice
Burri, L., Berge, K., Wibrand, K., Berge, R. K., & Barger, J. L. (2011) · Frontiers in Genetics · doi:10.3389/fgene.2011.00045 · Cited by 73 · see citing works
Cheki, M., Shirazi, A., Mahmoudzadeh, A., Bazzaz, J. T., & Hosseinimehr, S. J. (2016) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2016.09.001 · Cited by 72 · see citing works
AMPK is associated with the beneficial effects of antidiabetic agents on cardiovascular diseases
Lu, Q., Li, X., Liu, J., Sun, X., Rousselle, T., Ren, D., Tong, N., & Li, J. (2019) · Bioscience Reports · doi:10.1042/bsr20181995 · Cited by 69 · see citing works
Revisiting the mechanisms of metformin action in the liver
Viollet, B., & Foretz, M. (2013) · Annales d Endocrinologie · doi:10.1016/j.ando.2013.03.006 · Cited by 68 · see citing works
miR-378a: a new emerging microRNA in metabolism
Machado, I. F., Teodoro, J. S., Palmeira, C. M., & Rolo, A. P. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03375-z · Cited by 69 · see citing works
Larsen, A. H., Jessen, N., Nørrelund, H., Tolbod, L., Harms, H., Feddersen, S., Nielsen, F., Brøsen, K., Hansson, N. H., Frøkiær, J., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1656 · Cited by 54 · see citing works
Effect of Pioglitazone on the Metabolic and Hormonal Response to a Mixed Meal in Type II Diabetes
Gastaldelli, A., Casolaro, A., Pettiti, M., Nannipieri, M., Ciociaro, D., Frascerra, S., Buzzigoli, E., Baldi, S., Mari, A., & Ferrannini, E. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100034 · Cited by 68 · see citing works
Self-citationCardiovascular safety of anti-diabetic drugs
Kumar, R. B., Kerins, D. M., & Walther, T. (2015) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvv035 · Cited by 67 · see citing works
Nunez, D. J., Bush, M., Collins, D. A., McMullen, S. L., Gillmor, D., Apseloff, G., Atiee, G. J., Corsino, L., Morrow, L., & Feldman, P. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092494 · Cited by 65 · see citing works
Gormsen, L. C., Søndergaard, E., Christensen, N. L., Brøsen, K., Jessen, N., & Nielsen, S. (2019) · Diabetologia · doi:10.1007/s00125-019-4872-7 · Cited by 65 · see citing works
Abdul-Ghani, M. A., & DeFronzo, R. A. (2017) · Diabetes Care · doi:10.2337/dc16-2368 · Cited by 64 · see citing works
Wang, Y., Yang, Z., Zheng, G., Yu, L., Yin, Y., Mu, N., & Ma, H. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.04.002 · Cited by 63 · see citing works
Basu, R., Shah, P., Basu, A., Norby, B., Dicke, B., Chandramouli, V., Cohen, O., Landau, B. R., & Rizza, R. A. (2008) · Diabetes · doi:10.2337/db07-0827 · Cited by 63 · see citing works
Hesperidin prevents hyperglycemia in diabetic rats by activating the insulin receptor pathway
Peng, P., Jin, J., Zou, G., Sui, Y.-B., Han, Y., Zhao, D., & Liu, L. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9485 · Cited by 63 · see citing works
Adult-onset autoimmune diabetes
Buzzetti, R., Maddaloni, E., Gaglia, J. L., Leslie, R. D., Wong, F. S., & Boehm, B. O. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00390-6 · Cited by 64 · see citing works
Razavizade, M., Jamali, R., Arj, A., Matini, S. M., Moraveji, A., & Taherkhani, E. (2013) · Hepatitis Monthly · doi:10.5812/hepatmon.9270 · Cited by 59 · see citing works
Lü, J., Ji, J., Meng, H., Wang, D., Jiang, B., Liu, L., Randell, E. W., Adeli, K., & Meng, Q. H. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-58 · Cited by 56 · see citing works
Metformin-clinical pharmacology in PCOs.
Dumitrescu, R., Mehedințu, C., Briceag, I., Purcărea, V. L., & Hudita, D. (2015) · PubMed Central · Cited by 56 · see citing works
Takele, W. W., Vesco, K. K., Josefson, J., Redman, L. M., Hannah, W., Bonham, M. P., Chen, M., Chivers, S. C., Fawcett, A. J., Grieger, J. A., et al. (2024) · Communications Medicine · doi:10.1038/s43856-024-00491-1 · Cited by 55 · see citing works
Complications of Diabetes Therapy
Corathers, S. D., Peavie, S., & Salehi, M. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.06.005 · Cited by 58 · see citing works
Current strategies for the inhibition of hepatic glucose production in type 2 diabetes
Dale, S. E. (2009) · Frontiers in bioscience · doi:10.2741/3301 · Cited by 55 · see citing works
Repurposing Drugs to Target the Diabetes Epidemic
Turner, N. A., Zeng, X., Osborne, B., Rogers, S., & Ye, J.-M. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.01.007 · Cited by 59 · see citing works
Metformin, lipids and atherosclerosis prevention
Jenkins, A. J., Welsh, P. I., & Petrie, J. R. (2018) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000532 · Cited by 54 · see citing works
Home, P. D., & Pacini, G. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00761.x · Cited by 54 · see citing works
Low Utilization of Circulating Glucose after Food Withdrawal in Snell Dwarf Mice
Brooks, N. L., Trent, C. M., Raetzsch, C. F., Flurkey, K., Boysen, G., Perfetti, M. T., Jeong, Y.-C., Klebanov, S., Patel, K. B., Khodush, V. R., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700484200 · Cited by 51 · see citing works
Metformin and pioglitazone: effectively treating insulin resistance
Staels, B. (2006) · Current Medical Research and Opinion · doi:10.1185/030079906x112732 · Cited by 51 · see citing works
Top, W. M. C., Kooy, A., & Stehouwer, C. D. A. (2022) · Pharmaceuticals · doi:10.3390/ph15030312 · Cited by 48 · see citing works
Veelen, A., Erazo‐Tapia, E., Oscarsson, J., & Schrauwen, P. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101158 · Cited by 47 · see citing works
- Authors
- Natali, A., & Ferrannini, E.
- Affiliations
- University of Pisa (IT)
- Corresponding author
- Ferrannini, E.
- ORCID
- Natali, A.
- Venue
- Diabetologia
- Published
- 2006-02-14
- Volume
- 49
- Issue
- 3
- Pages
- 434-441
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2123472586
- Cited by
- 377
- References
- 32
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 5 · 2023: 27 · 2022: 24 · 2021: 27 · 2020: 23 · 2019: 22 · 2018: 25 · 2017: 23 · 2016: 20 · 2015: 20 · 2014: 13 · 2013: 27 · 2012: 17
- FWCI
- 2.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- metformin, thiazolidinediones, type 2 diabetes, hepatic glucose production, insulin resistance, glucose uptake, insulin sensitivity, glucose clearance, peroxisome proliferator-activated receptor gamma agonists, insulin-stimulated glucose disposal
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Drug Therapy, Combination, Glucose, Humans, Liver, Metformin, Thiazolidinediones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
